Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster
Sep 11, 2022
New Delhi [India], September 11 : Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous...